Significant reductions in all symptom scores after intervention in military personnel.
Cognitive processing therapy was directly compared with written exposure therapy for individuals with PTSD.
Individuals with chronic pain and PTSD have poor pain-related outcomes.
Mean reductions in Clinician-Administered PTSD Scale scores from baseline were significantly greater in the propranolol group compared with the placebo group.
Prolonged exposure therapy was associated with a greater reduction in PTSD symptom severity compared with a minimal-contact control.
Catatstrophic thinking about pain in children may mediate the relationship between chronic pain and PTSD.
In the military trauma setting, ketamine administration is not linked with PTSD.
The FDA has granted Breakthrough Therapy Designation to MDMA for treating PTSD.
Pregnant women with migraine are more likely to have PTSD.
Utilizing CPAP is thought to promote consolidation of emotional memory, which may assist in recovery from traumatic events.
Psychiatry Advisor Articles
- #MeToo: Helping Victims Cope With Sexual Harassment
- Clinician Insight: Exploring the Link Between Bipolar Disorder and Binge Eating Disorder
- Association Between Psychosis and Development of Dementia in Older Men
- Psychosis Could Be a Potential Side Effect of Steroid Treatment in Kids
- Effects of Antipsychotic Drugs on the Cardiovascular System
- Triiodothyronine in the Treatment of Bipolar Depression
- Nutritional Influences on Bipolar Disorder in Children
- Old Challenges and New Directions in Managing Tardive Dyskinesia
- Similar Rates of Childhood Trauma in Schizophrenia and Substance Use Disorders
- Potential for SERMs as Adjunctive Therapy for Schizophrenia
- Psychiatric Comorbidities Increase Neurologic Disability in Multiple Sclerosis
- Self-Regulation Interventions Beneficial for Children
- Traumatic Brain Injury Associated With Increased Risk for Dementia
- Adverse Neurodevelopmental and Mental Health Outcomes in PCOS
- Depression and Sleep Disturbances: Common Bedfellows